Currently viewing a development environment

Soren Emerson


Vanderbilt University

Soren Emerson is a an entering first year PhD student in the Vanderbilt University neuroscience program. He previously attended, and graduated from, Davidson College with a B.S. in neuroscience. He conducted three years of independent research at Davidson College under the mentorship of Dr. Mark Smith, a behavioral pharmacologist, and Dr. Rachid El Bejjani, a C. elegans neurobiologist. His research modeled the genetic and molecular mechanism of cocaine in C. elegans and the results of the project yielded a first author publication. At Vanderbilt, Soren plans to continue his research career in neuropharmacology.

Soren has authored 1 article

A new drug reduces risk of psychosis relapse in patients with dementia

Read now →

Pimavanserin has not received approval from the FDA, but study results are encouraging

Soren Emerson

Soren has shared 8 notes

Psilocybin reduced depression symptoms as much as a leading antidepressant

Read now →

New research compared the "magic mushrooms" component to Lexapro

What nematodes laying eggs tells us about how cocaine affects the brain

Read now →

New research uncovers a link between cocaine and acetylcholine that could eventually lead to new treatments for addiction

Drug overdose deaths in the US jumped nearly 30 percent in 2020

Read now →

The story behind these numbers is complex, but opioids have played a major role

Laughing gas could be the next tool against treatment-resistant depression

Read now →

A small clinical trial shows promise for people who don't find relief from antidepressants

Drinking way, way too much coffee might shrink your brain

Read now →

Up to five cups of coffee per day seems to be fine. Six or more? Your brain is going to feel it

New machine learning approach can identify your circadian rhythm from a blood sample

Read now →

Doctors do not currently monitor a person's circadian rhythms because there is not an efficient way to measure them

Tapering off opioids is treacherous for mental health

Read now →

A large-scale study shows how the opioid epidemic has created downstream negative health outcomes

Modified tree resins prevent zebrafish from having seizures

Read now →

Could these resins also be used to treat epilepsy in humans?

Soren has left Comment 4 peer comments

Could blockchain technology protect patients from counterfeit medication?

Read now →

Not so fast. We should be wary of trying to science our way out of large-scale health issues

Simon Spichak

Comment 2 peer comments

New drug addresses long overlooked "negative" symptoms of schizophrenia

Read now →

A data-driven search found a compound that shows promising results in early trials

Elizabeth Burnette

Comment 3 peer comments

We must reckon with our ableism if we want healthcare to work for people

Read now →

People who had COVID-19 may need long-term care — the US healthcare system isn't ready

Olivia Bernard

Comment 6 peer comments

The lab-leak hypothesis for COVID-19 is becoming a conspiracy theory

Read now →

To explain where SARS-CoV-2 came from, look at processes with scientific explanations and precedents

Dan Samorodnitsky

Comment 5 peer comments